Skip to main
FRLN
FRLN logo

FRLN Earnings Dates & Reports

FRLN Most Recent Earnings

Report DateDec 1, 2023
Period EndingQ3 2023
Est. EPS-$0.71
Actual EPS-$0.18
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FRLN Earnings per Share (EPS) History

Signup for full access
Browse free

FRLN Latest Earnings

The value each FRLN share was expected to gain vs. the value each share gained.

FRLN reported its most recent earnings on Dec 1, 2023 for Q3 2023, posting earnings per share (EPS) of -$0.18. This exceeded analysts' expectations of -$0.71 by 74.65%, marking a Beat.

For comparison, Freeline Therapeutics Holdings reported EPS of -$3 in the same quarter last year.

The company is expected to announce its next earnings report on 12/01/2023, with analysts projecting an EPS of $0.

FRLN Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2023Dec 1, 2023
-$0.71-$0.18-74.65%
DeckReportListen
Q2 2023Aug 15, 2023
-$3.14-$0.21-93.31%
DeckReportListen
Q1 2023May 30, 2023
-$3.10-$0.25-91.94%
DeckReportListen
Q4 2022Apr 4, 2023
-$4.20-$5.25+25.00%
DeckReportListen
Q3 2022Nov 15, 2022
-$6.60-$3.00-54.55%
DeckReportListen
View all

FRLN Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Freeline Therapeutics Holdings’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 15, 2023
May 30, 2023
Apr 4, 2023
Nov 15, 2022

FRLN Earnings FAQs

FRLN last reported earnings on Dec 1, 2023 for Q3 2023, posting an EPS of -$0.18, which Beat the estimate of -$0.71 by 74.65%.

For Q3 2023, FRLN reported an EPS of -$0.18, exceeding analysts' estimate of -$0.71 by 74.65%.

For Q3 2023, FRLN Beat expectations with an actual EPS of -$0.18 vs. an estimated EPS of -$0.71.

Following the last earnings report on Dec 1, 2023, FRLN's stock price moved — from — to —.

The next FRLN earnings call is scheduled for Dec. 1, 2023, where executives will discuss financial results and outlook.

Freeline Therapeutics Holdings (FRLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.